Summary: Eli Lilly announced that its weight-loss drug Zepbound (tirzepatide) reduced the severity of obstructive sleep apnea (OSA) by up to 63% in adults with obesity in two phase 3 trials. The drug improved sleep apnea symptoms in patients using and not using PAP therapy. Based … [Read more...]
Genio Neurostimulator Reduces Sleep Apnea Severity
Nyxoah SAs Desire US pivotal analyze, made to assist the advertising and marketing authorization of the Genio hypoglossal nerve stimulation procedure for obstructive sleep apnea in the United States, achieved a statistically substantial reduction in the co-key endpoints of … [Read more...]
Investigational Nasal Spray Modestly Reduces OSA Severity | Sleep Review
Australian researchers have discovered that a bedtime nasal spray has the potential to reduce the severity of obstructive sleep apnea (OSA) in people and lower their blood pressure. The research is published in The Journal of Heart and Circulatory Physiology. The study aimed to … [Read more...]
Daylight Saving Ups Severity of Medical Malpractice Incidents
Medical malpractice incidents are more severe during the months of the year when daylight saving time is observed in the United States, according to a new study that examined three decades of malpractice claims. Results show that both medical malpractice incident severity and … [Read more...]